1
|
Proteomic Studies of Blood and Vascular Wall in Atherosclerosis. Int J Mol Sci 2021; 22:ijms222413267. [PMID: 34948066 PMCID: PMC8707794 DOI: 10.3390/ijms222413267] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2021] [Revised: 12/02/2021] [Accepted: 12/07/2021] [Indexed: 12/12/2022] Open
Abstract
The review is devoted to the analysis of literature data related to the role of proteomic studies in the study of atherosclerotic cardiovascular diseases. Diagnosis of patients with atherosclerotic plaques before clinical manifestations is an arduous task. The review presents the results of research on the new proteomic potential biomarkers of coronary heart disease, coronary atherosclerosis, acute coronary syndrome, myocardial infarction, carotid artery atherosclerosis. Also, the analysis of literature data on proteomic studies of the vascular wall was carried out. To assess the involvement of proteins in the pathological process of atherosclerosis, it is important to investigate the specific relationships between proteins in the arteries, expression and concentration of proteins. The development of proteomic technologies has made it possible to analyse the number of proteins associated with the development of the disease. Analysis of the proteomic profile of the vascular wall in atherosclerosis can help to detect possible diagnostically significant protein structures or potential biomarkers of the disease and develop novel approaches to the diagnosis of atherosclerosis and its complications.
Collapse
|
2
|
Klich A, Mercier C, Gerfault L, Grangeat P, Beaulieu C, Degout-Charmette E, Fortin T, Mahé P, Giovannelli JF, Charrier JP, Giremus A, Maucort-Boulch D, Roy P. Variance component analysis to assess protein quantification in biomarker validation: application to selected reaction monitoring-mass spectrometry. BMC Bioinformatics 2018; 19:73. [PMID: 29490628 PMCID: PMC5831836 DOI: 10.1186/s12859-018-2075-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2017] [Accepted: 02/20/2018] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND In the field of biomarker validation with mass spectrometry, controlling the technical variability is a critical issue. In selected reaction monitoring (SRM) measurements, this issue provides the opportunity of using variance component analysis to distinguish various sources of variability. However, in case of unbalanced data (unequal number of observations in all factor combinations), the classical methods cannot correctly estimate the various sources of variability, particularly in presence of interaction. The present paper proposes an extension of the variance component analysis to estimate the various components of the variance, including an interaction component in case of unbalanced data. RESULTS We applied an experimental design that uses a serial dilution to generate known relative protein concentrations and estimated these concentrations by two processing algorithms, a classical and a more recent one. The extended method allowed estimating the variances explained by the dilution and the technical process by each algorithm in an experiment with 9 proteins: L-FABP, 14.3.3 sigma, Calgi, Def.A6, Villin, Calmo, I-FABP, Peroxi-5, and S100A14. Whereas, the recent algorithm gave a higher dilution variance and a lower technical variance than the classical one in two proteins with three peptides (L-FABP and Villin), there were no significant difference between the two algorithms on all proteins. CONCLUSIONS The extension of the variance component analysis was able to estimate correctly the variance components of protein concentration measurement in case of unbalanced design.
Collapse
Affiliation(s)
- Amna Klich
- Service de Biostatistique-Bioinformatique, Hospices Civils de Lyon, 162, avenue Lacassagne, F-69003, Lyon, France. .,Université de Lyon, Lyon, France. .,PRABI, Université Lyon 1, Villeurbanne, France. .,CNRS UMR 5558, LBBE, Équipe Biostatistique Santé, Villeurbanne, France.
| | - Catherine Mercier
- Service de Biostatistique-Bioinformatique, Hospices Civils de Lyon, 162, avenue Lacassagne, F-69003, Lyon, France.,Université de Lyon, Lyon, France.,PRABI, Université Lyon 1, Villeurbanne, France.,CNRS UMR 5558, LBBE, Équipe Biostatistique Santé, Villeurbanne, France
| | - Laurent Gerfault
- Université Grenoble-Alpes, F-38000, Grenoble, France.,Commissariat à l'Énergie Atomique, Laboratoire d'Électronique et de Technologie de l'Information, MINATEC Campus, Département Micro-technologies pour la Biologie et la Santé, F-38054, Grenoble, France
| | - Pierre Grangeat
- Université Grenoble-Alpes, F-38000, Grenoble, France.,Commissariat à l'Énergie Atomique, Laboratoire d'Électronique et de Technologie de l'Information, MINATEC Campus, Département Micro-technologies pour la Biologie et la Santé, F-38054, Grenoble, France
| | - Corinne Beaulieu
- Innovation Unit, Technology Research Department, bioMérieux, F-69280, Marcy l'Étoile, France
| | - Elodie Degout-Charmette
- Innovation Unit, Technology Research Department, bioMérieux, F-69280, Marcy l'Étoile, France
| | - Tanguy Fortin
- Innovation Unit, Technology Research Department, bioMérieux, F-69280, Marcy l'Étoile, France.,, Present Address: Villeurbanne, France
| | - Pierre Mahé
- Innovation Unit, Technology Research Department, bioMérieux, F-38000, Grenoble, France
| | - Jean-François Giovannelli
- Intégration du Matériau au Système (Université de Bordeaux, CNRS, Bordeaux Aquitaine INP), F-33400, Talence, France
| | - Jean-Philippe Charrier
- Innovation Unit, Technology Research Department, bioMérieux, F-69280, Marcy l'Étoile, France
| | - Audrey Giremus
- Intégration du Matériau au Système (Université de Bordeaux, CNRS, Bordeaux Aquitaine INP), F-33400, Talence, France
| | - Delphine Maucort-Boulch
- Service de Biostatistique-Bioinformatique, Hospices Civils de Lyon, 162, avenue Lacassagne, F-69003, Lyon, France.,Université de Lyon, Lyon, France.,PRABI, Université Lyon 1, Villeurbanne, France.,CNRS UMR 5558, LBBE, Équipe Biostatistique Santé, Villeurbanne, France
| | - Pascal Roy
- Service de Biostatistique-Bioinformatique, Hospices Civils de Lyon, 162, avenue Lacassagne, F-69003, Lyon, France.,Université de Lyon, Lyon, France.,PRABI, Université Lyon 1, Villeurbanne, France.,CNRS UMR 5558, LBBE, Équipe Biostatistique Santé, Villeurbanne, France
| |
Collapse
|
3
|
Dupin M, Fortin T, Larue-Triolet A, Surault I, Beaulieu C, Gouel-Chéron A, Allaouchiche B, Asehnoune K, Roquilly A, Venet F, Monneret G, Lacoux X, Roitsch CA, Pachot A, Charrier JP, Pons S. Impact of Serum and Plasma Matrices on the Titration of Human Inflammatory Biomarkers Using Analytically Validated SRM Assays. J Proteome Res 2016; 15:2366-78. [DOI: 10.1021/acs.jproteome.5b00803] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
| | | | | | | | | | - Aurélie Gouel-Chéron
- Hospices Civils de Lyon (HCL), Hôpital Edouard
Herriot, Département d’Anesthésie-Réanimation, Lyon, France
| | - Bernard Allaouchiche
- Hospices Civils de Lyon (HCL), Hôpital Edouard
Herriot, Département d’Anesthésie-Réanimation, Lyon, France
- EA
4174, Hémostase, Inflammation et Sepsis, Hospices Civils de Lyon - Université Claude Bernard Lyon 1, Lyon, France
| | - Karim Asehnoune
- CHU Nantes, Hôtel Dieu, Département
d’anesthésie réanimation chirurgicale, Nantes, France
| | - Antoine Roquilly
- CHU Nantes, Hôtel Dieu, Département
d’anesthésie réanimation chirurgicale, Nantes, France
| | - Fabienne Venet
- Hospices Civils de Lyon (HCL), Hôpital Edouard
Herriot, Laboratoire d’Immunologie Cellulaire, Lyon, France
- EA
4174, Hémostase, Inflammation et Sepsis, Hospices Civils de Lyon - Université Claude Bernard Lyon 1, Lyon, France
- Laboratoire
Commun de Recherche HCL - bioMérieux, Hospices Civils de Lyon, Hôpital E. Herriot, Lyon, France
| | - Guillaume Monneret
- Hospices Civils de Lyon (HCL), Hôpital Edouard
Herriot, Laboratoire d’Immunologie Cellulaire, Lyon, France
- EA
4174, Hémostase, Inflammation et Sepsis, Hospices Civils de Lyon - Université Claude Bernard Lyon 1, Lyon, France
- Laboratoire
Commun de Recherche HCL - bioMérieux, Hospices Civils de Lyon, Hôpital E. Herriot, Lyon, France
| | | | | | | | | | | |
Collapse
|
4
|
Walmsley SJ, Rudnick PA, Liang Y, Dong Q, Stein SE, Nesvizhskii AI. Comprehensive analysis of protein digestion using six trypsins reveals the origin of trypsin as a significant source of variability in proteomics. J Proteome Res 2013; 12:5666-80. [PMID: 24116745 DOI: 10.1021/pr400611h] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Trypsin is an endoprotease commonly used for sample preparation in proteomics experiments. Importantly, protein digestion is dependent on multiple factors, including the trypsin origin and digestion conditions. In-depth characterization of trypsin activity could lead to improved reliability of peptide detection and quantitation in both targeted and discovery proteomics studies. To this end, we assembled a data analysis pipeline and suite of visualization tools for quality control and comprehensive characterization of preanalytical variability in proteomics experiments. Using these tools, we evaluated six available proteomics-grade trypsins and their digestion of a single purified protein, human serum albumin (HSA). HSA was aliquoted and then digested for 2 or 18 h for each trypsin, and the resulting digests were desalted and analyzed in triplicate by reversed-phase liquid chromatography-tandem mass spectrometry. Peptides were identified and quantified using the NIST MSQC pipeline and a comprehensive HSA mass spectral library. We performed a statistical analysis of peptide abundances from different digests and further visualized the data using the principal component analysis and quantitative protein "sequence maps". While the performance of individual trypsins across repeat digests was reproducible, significant differences were observed depending on the origin of the trypsin (i.e., bovine vs porcine). Bovine trypsins produced a higher number of peptides containing missed cleavages, whereas porcine trypsins produced more semitryptic peptides. In addition, many cleavage sites showed variable digestion kinetics patterns, evident from the comparison of peptide abundances in 2 h vs 18 h digests. Overall, this work illustrates effects of an often neglected source of variability in proteomics experiments: the origin of the trypsin.
Collapse
Affiliation(s)
- Scott J Walmsley
- Department of Pathology, University of Michigan , 4237 Medical Science I, 1301 Catherine Road, Ann Arbor, Michigan 48109, United States
| | | | | | | | | | | |
Collapse
|
5
|
Abbatiello SE, Mani DR, Schilling B, Maclean B, Zimmerman LJ, Feng X, Cusack MP, Sedransk N, Hall SC, Addona T, Allen S, Dodder NG, Ghosh M, Held JM, Hedrick V, Inerowicz HD, Jackson A, Keshishian H, Kim JW, Lyssand JS, Riley CP, Rudnick P, Sadowski P, Shaddox K, Smith D, Tomazela D, Wahlander A, Waldemarson S, Whitwell CA, You J, Zhang S, Kinsinger CR, Mesri M, Rodriguez H, Borchers CH, Buck C, Fisher SJ, Gibson BW, Liebler D, Maccoss M, Neubert TA, Paulovich A, Regnier F, Skates SJ, Tempst P, Wang M, Carr SA. Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS). Mol Cell Proteomics 2013; 12:2623-39. [PMID: 23689285 DOI: 10.1074/mcp.m112.027078] [Citation(s) in RCA: 92] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
Multiple reaction monitoring (MRM) mass spectrometry coupled with stable isotope dilution (SID) and liquid chromatography (LC) is increasingly used in biological and clinical studies for precise and reproducible quantification of peptides and proteins in complex sample matrices. Robust LC-SID-MRM-MS-based assays that can be replicated across laboratories and ultimately in clinical laboratory settings require standardized protocols to demonstrate that the analysis platforms are performing adequately. We developed a system suitability protocol (SSP), which employs a predigested mixture of six proteins, to facilitate performance evaluation of LC-SID-MRM-MS instrument platforms, configured with nanoflow-LC systems interfaced to triple quadrupole mass spectrometers. The SSP was designed for use with low multiplex analyses as well as high multiplex approaches when software-driven scheduling of data acquisition is required. Performance was assessed by monitoring of a range of chromatographic and mass spectrometric metrics including peak width, chromatographic resolution, peak capacity, and the variability in peak area and analyte retention time (RT) stability. The SSP, which was evaluated in 11 laboratories on a total of 15 different instruments, enabled early diagnoses of LC and MS anomalies that indicated suboptimal LC-MRM-MS performance. The observed range in variation of each of the metrics scrutinized serves to define the criteria for optimized LC-SID-MRM-MS platforms for routine use, with pass/fail criteria for system suitability performance measures defined as peak area coefficient of variation <0.15, peak width coefficient of variation <0.15, standard deviation of RT <0.15 min (9 s), and the RT drift <0.5min (30 s). The deleterious effect of a marginally performing LC-SID-MRM-MS system on the limit of quantification (LOQ) in targeted quantitative assays illustrates the use and need for a SSP to establish robust and reliable system performance. Use of a SSP helps to ensure that analyte quantification measurements can be replicated with good precision within and across multiple laboratories and should facilitate more widespread use of MRM-MS technology by the basic biomedical and clinical laboratory research communities.
Collapse
Affiliation(s)
- Susan E Abbatiello
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Tabb DL. Quality assessment for clinical proteomics. Clin Biochem 2012; 46:411-20. [PMID: 23246537 DOI: 10.1016/j.clinbiochem.2012.12.003] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2012] [Revised: 12/01/2012] [Accepted: 12/03/2012] [Indexed: 12/21/2022]
Abstract
Proteomics has emerged from the labs of technologists to enter widespread application in clinical contexts. This transition, however, has been hindered by overstated early claims of accuracy, concerns about reproducibility, and the challenges of handling batch effects properly. New efforts have produced sets of performance metrics and measurements of variability that establish sound expectations for experiments in clinical proteomics. As researchers begin incorporating these metrics in a quality by design paradigm, the variability of individual steps in experimental pipelines will be reduced, regularizing overall outcomes. This review discusses the evolution of quality assessment in 2D gel electrophoresis, mass spectrometry-based proteomic profiling, tandem mass spectrometry-based protein inventories, and proteomic quantitation. Taken together, the advances in each of these technologies are establishing databases that will be increasingly useful for decision-making in clinical experimentation.
Collapse
Affiliation(s)
- David L Tabb
- Department of Biomedical Informatics, Vanderbilt University, USA.
| |
Collapse
|
7
|
Mani DR, Abbatiello SE, Carr SA. Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics. BMC Bioinformatics 2012; 13 Suppl 16:S9. [PMID: 23176545 PMCID: PMC3489552 DOI: 10.1186/1471-2105-13-s16-s9] [Citation(s) in RCA: 82] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Multiple reaction monitoring mass spectrometry (MRM-MS) with stable isotope dilution (SID) is increasingly becoming a widely accepted assay for the quantification of proteins and peptides. These assays have shown great promise in relatively high throughput verification of candidate biomarkers. While the use of MRM-MS assays is well established in the small molecule realm, their introduction and use in proteomics is relatively recent. As such, statistical and computational methods for the analysis of MRM-MS data from proteins and peptides are still being developed. Based on our extensive experience with analyzing a wide range of SID-MRM-MS data, we set forth a methodology for analysis that encompasses significant aspects ranging from data quality assessment, assay characterization including calibration curves, limits of detection (LOD) and quantification (LOQ), and measurement of intra- and interlaboratory precision. We draw upon publicly available seminal datasets to illustrate our methods and algorithms.
Collapse
Affiliation(s)
- D R Mani
- The Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02142, USA.
| | | | | |
Collapse
|
8
|
Analysis of Sasang constitutional types using facial features with compensation for photographic distance. Integr Med Res 2012; 1:26-35. [PMID: 28664044 PMCID: PMC5481682 DOI: 10.1016/j.imr.2012.09.003] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2012] [Revised: 09/17/2012] [Accepted: 09/25/2012] [Indexed: 11/30/2022] Open
Abstract
Background Facial features are regarded as representative and reliable characteristics for diagnosing a person's Sasang Constitution (SC). However, the description of these features tends to depend on the interpretation and the opinion of the doctor that follows the SC approach. In this paper, we performed a facial feature analysis of SC types in an objective and quantitative manner. Here, site-to-site variability can be an obstacle to properly analyzing facial features when images are taken from various sites, which may have different experimental environments. A compensation technique to reduce the site-to-site variability was proposed before performing the feature analysis. Methods The frontal and profile images of 1464 patients recruited from various oriental medical clinics (19 sites) were used. Candidate feature variables were created, which were inspired by the facial characteristics of the SC types described in the Sasang constitutional medicine literature. To resolve the problems involved in processing data collected from various sites with heterogeneous experimental environments, a compensation technique was proposed. Statistical analysis techniques were employed to observe the differences among the SC types and to demonstrate how effectively the site-to-site variability was reduced. Results The facial features that were significant for diagnosing the SC types were identified by a statistical analysis, and it was verified that the compensation technique reduced the site-to-site variability produced by the differences in photographic distance. Conclusion It is noted that the significant facial features represent common characteristics of each SC type in the sense that we collected extensive opinions from many Sasang constitutional medicine doctors with various points of view. Additionally, a compensation method for the photographic distance is needed to find the significant facial features. We expect these findings and the related compensation technique to contribute to establishing a scientific basis for the precise diagnosis of SC types in clinical practice.
Collapse
|
9
|
Pailleux F, Beaudry F. Internal standard strategies for relative and absolute quantitation of peptides in biological matrices by liquid chromatography tandem mass spectrometry. Biomed Chromatogr 2012; 26:881-91. [DOI: 10.1002/bmc.2757] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2012] [Accepted: 04/23/2012] [Indexed: 01/08/2023]
Affiliation(s)
| | - Francis Beaudry
- Groupe de Recherche en Pharmacologie Animal du Québec (GREPAQ), Département de biomédecine vétérinaire, Faculté de médecine vétérinaire; Université de Montréal, Saint-Hyacinthe; Québec; Canada
| |
Collapse
|
10
|
Heikkinen AT, Friedlein A, Lamerz J, Jakob P, Cutler P, Fowler S, Williamson T, Tolando R, Lave T, Parrott N. Mass spectrometry-based quantification of CYP enzymes to establish in vitro/in vivo scaling factors for intestinal and hepatic metabolism in beagle dog. Pharm Res 2012; 29:1832-42. [PMID: 22354837 DOI: 10.1007/s11095-012-0707-7] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2011] [Accepted: 02/08/2012] [Indexed: 11/25/2022]
Abstract
PURPOSE Physiologically based models, when verified in pre-clinical species, optimally predict human pharmacokinetics. However, modeling of intestinal metabolism has been a gap. To establish in vitro/in vivo scaling factors for metabolism, the expression and activity of CYP enzymes were characterized in the intestine and liver of beagle dog. METHODS Microsomal protein abundance in dog tissues was determined using testosterone-6β-hydroxylation and 7-hydroxycoumarin-glucuronidation as markers for microsomal protein recovery. Expressions of 7 CYP enzymes were estimated based on quantification of proteotypic tryptic peptides using multiple reaction monitoring mass spectrometry. CYP3A12 and CYP2B11 activity was evaluated using selective marker reactions. RESULTS The geometric mean of total microsomal protein was 51 mg/g in liver and 13 mg/cm in intestine, without significant differences between intestinal segments. CYP3A12, followed by CYP2B11, were the most abundant CYP enzymes in intestine. Abundance and activity were higher in liver than intestine and declined from small intestine to colon. CONCLUSIONS CYP expression in dog liver and intestine was characterized, providing a basis for in vitro/in vivo scaling of intestinal and hepatic metabolism.
Collapse
Affiliation(s)
- Aki T Heikkinen
- Non-Clinical Safety, Pharmaceuticals Division, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, B70/R130, CH-4070 Basel, Switzerland
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Chang CY, Picotti P, Hüttenhain R, Heinzelmann-Schwarz V, Jovanovic M, Aebersold R, Vitek O. Protein significance analysis in selected reaction monitoring (SRM) measurements. Mol Cell Proteomics 2011; 11:M111.014662. [PMID: 22190732 DOI: 10.1074/mcp.m111.014662] [Citation(s) in RCA: 116] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Selected reaction monitoring (SRM) is a targeted mass spectrometry technique that provides sensitive and accurate protein detection and quantification in complex biological mixtures. Statistical and computational tools are essential for the design and analysis of SRM experiments, particularly in studies with large sample throughput. Currently, most such tools focus on the selection of optimized transitions and on processing signals from SRM assays. Little attention is devoted to protein significance analysis, which combines the quantitative measurements for a protein across isotopic labels, peptides, charge states, transitions, samples, and conditions, and detects proteins that change in abundance between conditions while controlling the false discovery rate. We propose a statistical modeling framework for protein significance analysis. It is based on linear mixed-effects models and is applicable to most experimental designs for both isotope label-based and label-free SRM workflows. We illustrate the utility of the framework in two studies: one with a group comparison experimental design and the other with a time course experimental design. We further verify the accuracy of the framework in two controlled data sets, one from the NCI-CPTAC reproducibility investigation and the other from an in-house spike-in study. The proposed framework is sensitive and specific, produces accurate results in broad experimental circumstances, and helps to optimally design future SRM experiments. The statistical framework is implemented in an open-source R-based software package SRMstats, and can be used by researchers with a limited statistics background as a stand-alone tool or in integration with the existing computational pipelines.
Collapse
Affiliation(s)
- Ching-Yun Chang
- Department of Statistics, Purdue University, West Lafayette, Indiana, USA
| | | | | | | | | | | | | |
Collapse
|
12
|
Florentinus AK, Bowden P, Sardana G, Diamandis EP, Marshall JG. Identification and quantification of peptides and proteins secreted from prostate epithelial cells by unbiased liquid chromatography tandem mass spectrometry using goodness of fit and analysis of variance. J Proteomics 2011; 75:1303-17. [PMID: 22120120 DOI: 10.1016/j.jprot.2011.11.002] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2011] [Revised: 10/29/2011] [Accepted: 11/05/2011] [Indexed: 10/15/2022]
Abstract
The proteins secreted by prostate cancer cells (PC3(AR)6) were separated by strong anion exchange chromatography, digested with trypsin and analyzed by unbiased liquid chromatography tandem mass spectrometry with an ion trap. The spectra were matched to peptides within proteins using a goodness of fit algorithm that showed a low false positive rate. The parent ions for MS/MS were randomly and independently sampled from a log-normal population and therefore could be analyzed by ANOVA. Normal distribution analysis confirmed that the parent and fragment ion intensity distributions were sampled over 99.9% of their range that was above the background noise. Arranging the ion intensity data with the identified peptide and protein sequences in structured query language (SQL) permitted the quantification of ion intensity across treatments, proteins and peptides. The intensity of 101,905 fragment ions from 1421 peptide precursors of 583 peptides from 233 proteins separated over 11 sample treatments were computed together in one ANOVA model using the statistical analysis system (SAS) prior to Tukey-Kramer honestly significant difference (HSD) testing. Thus complex mixtures of proteins were identified and quantified with a high degree of confidence using an ion trap without isotopic labels, multivariate analysis or comparing chromatographic retention times.
Collapse
|